Movatterモバイル変換


[0]ホーム

URL:


Wayback Machine
21 captures
20 Aug 2008 - 20 Apr 2023
JulAUGOct
Previous capture20Next capture
200720082011
success
fail
COLLECTED BY
Collection:Common Crawl
Web crawl data from Common Crawl.
TIMESTAMPS
loading
The Wayback Machine - https://web.archive.org/web/20080820004729/http://archive.rubicon-foundation.org/2573
DSpace
 

Advanced Search
Home
 
Browse
Communities
& Collections
Titles
Authors
By Date
 
Sign on to:
Receive email
updates
My Rubicon
authorized users
Edit Profile
 

Rubicon Research Repository >
Rubicon Foundation Archive >
Undersea Biomedical Research Journal >

Please use this identifier to cite or link to this item:http://archive.rubicon-foundation.org/2573

Title: Hyperbaric oxygen and scopolamine
Authors: Bitterman, N
Eilender, E
Melamed, Y
Keywords: pharmacology
drug
hyperbaric
scopolamine
animal
rat
Issue Date: 1991
Abstract: Scopolamine (Hyoscine), an anticholinergic compound is widely used for the prophylaxis and treatment of motion sickness and might be used with oxygen diving and hyperbaric oxygen therapy. We therefore decided to test the interaction of scopolamine with oxygen at high pressure. Thirty-six rats implanted with cortical EEG electrodes were injected subcutaneously with two doses of scopolamine (0.02 or 0.2 mg.kg-1), or the vehicle (saline), 30 min before exposure to 5 atm abs (0.5 MPa) oxygen. Electroencephalogram and heart rate were monitored continuously. Spectral analysis of the EEG was carried out, and the duration of the latent period before convulsions was determined. No significant difference was found in the duration of the latent period between the control rats receiving vehicle (saline) and rats injected with scopolamine (n = 12 for each group). Changes in background EEG activity and maximal dilation of the pupil were detected at both scopolamine doses. Heart rate significantly decreased at 0.02 mg.kg-1 and increased at the dose of 0.2 mg.kg-1 scopolamine. Our findings indicate that the duration of the latent period preceding hyperoxic seizures is not altered by scopolamine in rats; however, other side effects of the drug regarding visual and cardiovascular symptoms should be considered when scopolamine is used in combination with hyperbaric oxygen.
Description: Undersea and Hyperbaric Medical Society, Inc. (http://www.uhms.org )
URI: PMID: 1853467
http://archive.rubicon-foundation.org/2573
Appears in Collections:Undersea Biomedical Research Journal

Files in This Item:

FileSizeFormat
1853467.pdf1225KbAdobe PDFView/Open

All items in DSpace are protected by copyright, with all rights reserved.

 

  Copyright © 2004-2006 Rubicon Foundation, Inc. -Feedback

[8]ページ先頭

©2009-2025 Movatter.jp